A two-drug combination therapy for cystic fibrosis is shown to be effective. Triple combination therapy is close behind.
Published in Research
Successful Phase III trials at UAB contributed to the development of a novel “corrector-potentiator” combination drug therapy for cystic fibrosis patients.
Published in Research
UAB and UMass researchers have uncovered a new mechanistic understanding of potential treatment for genetic disorders.
Published in Research
Cystic fibrosis lung cells were restored to 50 percent of healthy function in work that provides the first evidence that novel therapeutic strategies for human patients can be identified based on yeast studies.
Published in Research
Southern Research and UAB launch a search for compounds that might provide new therapies for CF nonsense mutations.
Published in Research
The Cystic Fibrosis Foundation recognizes UAB’s Adult CF Program with Quality Care Award.
Published in People of UAB
UAB was part of a promising international study of a combination therapy for patients with the most common cystic fibrosis mutation.
Published in Research

Blending invention with necessity, UAB professionals use a little ingenuity to help a patient prepare for a lung transplant.

Published in Health & Medicine

Investigators have developed a new imaging method to enhance research into new treatments.

Published in Research

UAB researchers find spiritual coping a predictor of mental health in chronically ill youth; recommend clinicians assess spirituality.

Published in Research

Physical therapy faculty member elected chair of a national specialty board.

Published in People of UAB
Back to Top